Description

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores key considerations for choosing antiretroviral therapy (ART) for pediatric patients.

Listen as she gives perspectives on:

• Department of Health and Human Services (DHHS) guideline recommendations for infants at risk for perinatal HIV transmission
• DHHS guideline–recommended ART regimens for children
• The ODYSSEY A and B studies evaluating dolutegravir-based ART in children and adolescents
• Data for the use of the fixed-dose combination bictegravir/emtricitabine/tenofovir alafenamide in children and adolescents
• Key ART and management considerations for adolescents and young adults with HIV

Presenter:

Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS
Assistant Professor of Pediatrics
Division of Pediatric Infectious Diseases
Pediatric and Adolescent HIV  
Children’s Hospital at Montefiore
Pediatric Hospital of Albert Einstein  
College of Medicine
Bronx, New York  

Follow along with the slides at:
https://bit.ly/3wMur29

Link to full program:
https://bit.ly/3fOl0XX

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.